GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
LDE225 and Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering talks about a ...
Dr. Cathy Pietanza of Memorial Sloan Kettering talks about a drug currently in clinical trials that may successfully treat small cell lung cancer. February 2014.
-
HD
Is There a Silver Bullet for Small Cell Lung Cancer?
Dr. Cathy Pietanza of Memorial Sloan Kettering discusses potential areas ...
Dr. Cathy Pietanza of Memorial Sloan Kettering discusses potential areas of success in the treatment of small cell lung cancer. February 2014.
-
HD
Advice for Newly Diagnosed Small Cell Lung Cancer Patients
Dr. Cathy Pietanza of Memorial Sloan Kettering offers suggestions for ...
Dr. Cathy Pietanza of Memorial Sloan Kettering offers suggestions for newly diagnosed small cell lung cancer patients. February 2014.
-
HD
PARP Inhibitors in Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering talks about the ...
Dr. Cathy Pietanza of Memorial Sloan Kettering talks about the role of PARP inhibitors in the treatment of small cell lung cancer. February 2014.
-
HD
What's the Status and Potential Utility of Cabozantinib in Lung Cancer?
Dr. Heather Wakelee of Stanford University Medical Center discusses whether ...
Dr. Heather Wakelee of Stanford University Medical Center discusses whether or not cabozantinib - a drug already approved for thyroid cancer - can help patients with lung cancer. February 2014.
-
HD
MK-3475 and its Efficacy in Lung Cancer
Dr. Edward Garon discusses what researchers are learning about MK-3475, ...
Dr. Edward Garon discusses what researchers are learning about MK-3475, an immune therapy treatment currently in clinical trial. February 2014.
-
HD
How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?
Dr. Edward Garon warns that it is still too early ...
Dr. Edward Garon warns that it is still too early to compare which immune therapies will be more effective in treating lung cancer.February 2014.
-
HD
Do you see PARP inhibitors as a single drug therapy or more in a combination setting?
Dr. Cathy Pietanza of Memorial Sloan Kettering discusses whether PARP ...
Dr. Cathy Pietanza of Memorial Sloan Kettering discusses whether PARP treatments can be taken alone or if they must be taken with other drugs. February 2014.
-
HD
Late Stage Oropharynx Cancer, Chemotherapy - Options and Practice (video)
Dr. Jared Weiss, University of North Carolina, discusses chemotherapy options ...
Dr. Jared Weiss, University of North Carolina, discusses chemotherapy options and practice in late stage oropharynx cancer.
-
HD
Late Stage Oropharynx Cancer, Chemotherapy - Options and Practice (audio)
Dr. Jared Weiss, University of North Carolina, discusses chemotherapy options ...
Dr. Jared Weiss, University of North Carolina, discusses chemotherapy options and practice in late stage oropharynx cancer.
